Company Search:
Advanced Search
Sponsored Links
Innoviva Inc Company Snapshot
Innoviva Inc operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Innoviva Inc with three other companies in this sector in UNITED STATES : Corcept Therapeutics Incorporated (2020 sales of $353.87 million of which 100% was tion of Pharmaceutical products), Organogenesis Holdings Inc ($338.30 million of which 100% was regenerative medicine), and Amphastar Pharmaceuticals Inc ($349.85 million of which 95% was Pharmaceutical).

Sales Analysis. During the second quarter of 2021, sales at Innoviva Inc totalled $100.81 million. This is an increase of 27.7% from the $78.95 million in sales at the company during the second quarter of 2020. During the first two quarters of 2021, sales totalled $186.32 million, which is 18.2% higher than through the first two quarters of 2020. During the previous 6 quarters, sales at Innoviva Inc have increased compared with the same quarter in the previous year. There appears to be at least some degree of seasonality in the sales at Innoviva Inc: during 8 of the previous 9 years, sales were highest during the fourth quarter. The exception to this was during 2012, when the first quarter was the best quarter, accounting for 94% of sales (during that same year, the fourth quarter accounted for 4% of sales). During the year ended December of 2020, sales at Innoviva Inc were $336.79 million. This is an increase of 29.0% versus 2019, when the company's sales were $261.02 million. This was the fifth consecutive year of sales increases at Innoviva Inc (and since 2015, sales have increased a total of 524%).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Innoviva Inc
  Stock Performance Chart for Innoviva Inc
  Stock Data: Recent Stock Performance:
  Current Price (9/17/2021): 15.65
(Figures in U.S. Dollars)
1 Week 0.8%   13 Weeks -1.8%  
4 Weeks 17.4%   52 Weeks 35.3%  
Innoviva Inc Key Data:
  Ticker: INVA Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2020 Sales 336,794,000
(Year Ending Jan 2021).
Employees: 5
  Currency: U.S. Dollars Market Cap: 1,087,596,750
  Fiscal Yr Ends: December Shares Outstanding: 69,495,000
  Share Type: Common Closely Held Shares: 473,189
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.